UTHR

United Therapeutics Stock Price

172.82
5.56 (3.32%)
Upgrade to Real-Time
Afterhours (Closed)
172.82
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
United Therapeutics Corporation UTHR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
5.56 3.32% 172.82 20:00:00
Open Price Low Price High Price Close Price Prev Close
165.70 165.70 173.72 172.82 167.26
Bid Price Ask Price Spread News
138.00 333.00 195.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,216 719,231 $ 170.03 $ 122,290,171 374,783 75.58 - 173.72
Last Trade Time Type Quantity Stock Price Currency
16:57:36 priorref 168 $ 172.82 USD

United Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.68B 44.44M 39.03M $ 1.45B $ 548.66M -2.45 15.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -1.51k 0.20%

more financials information »

United Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical UTHR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week167.75173.72160.5015165.71387,9085.073.02%
1 Month149.07173.72143.35156.97389,93623.7515.93%
3 Months123.10173.72120.76142.13404,03349.7240.39%
6 Months121.33173.7298.37125.69357,06451.4942.44%
1 Year91.27173.7275.58113.27462,73481.5589.35%
3 Years140.98173.7274.31106.43437,80931.8422.58%
5 Years133.44173.7274.31115.55480,16639.3829.51%

United Therapeutics Description

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.


Your Recent History
NASDAQ
UTHR
United The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.